Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Assessment of Third Trimester Post-void Residual and Validation of Bladder Scanner in Pregnancy and Post-partum

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Michael Stitely, West Virginia University
ClinicalTrials.gov Identifier:
NCT00782730
First received: October 29, 2008
Last updated: June 11, 2013
Last verified: June 2013

October 29, 2008
June 11, 2013
October 2008
December 2009   (final data collection date for primary outcome measure)
Define normal post-void residual volume in third trimester pregnancy and post-partum. [ Time Frame: 12-24 hours ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00782730 on ClinicalTrials.gov Archive Site
Calculate the validity of measurements form the bladder scanner ultrasound for bladder volumes during the third trimester of pregnancy and post-partum. [ Time Frame: 12-24 hours ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Assessment of Third Trimester Post-void Residual and Validation of Bladder Scanner in Pregnancy and Post-partum
Assessment of Third Trimester Post-void Residual Along With Determining Validity of the Bladder Scanner in the Third Trimester of Pregnancy and Postpartum

This will be a descriptive study measuring the post—void residual of patients in the third trimester and postpartum. Also, bladder scan values will be compared to the amount of urine obtained from a Foley catheter to determine the accuracy of the bladder scanner in the third trimester and postpartum.

Not Provided
Observational
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

All adult patients undergoing elective or non-emergent Cesarean delivery will be asked to enroll. Also adult patients having a labor epidural placed during labor will be asked to participate.

Pregnancy
Not Provided
Bladder Scan Group
Patients who agree to enroll in the trial and allow their known bladder volumes and residual bladder volumes to be measured by actual volumes retrograde instilled, and also by bladder scanner ultrasound.
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
35
Not Provided
December 2009   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Age greater than 18 years.
  • Having a non-emergent Cesarean Delivery or labor epidural placed.

Exclusion Criteria:

  • Age less than 18 years.
  • Emergent Cesarean delivery.
  • No epidural labor analgesia.
Female
18 Years and older
No
Contact information is only displayed when the study is recruiting subjects
United States
 
NCT00782730
H-20862
No
Michael Stitely, West Virginia University
West Virginia University
Not Provided
Principal Investigator: Michael L Stitely, MD West Virginia University
West Virginia University
June 2013

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP